News ReleaseFor Immediate Release |
 |
Investor Contact (Merge):
Julie Pekarek
Chief Marketing Officer
414.977.4254
ir@merge.com
ETRIALS WORLDWIDE TO REPORT FIRST QUARTER 2009 FINANCIAL RESULTS
Morrisville, NC, April 24, 2009 – etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services designed to optimize clinical trial management by turning data into intelligence and shortening the pathway to an actionable study endpoint, today announced it will release financial results for the three months ended March 31, 2009 on Tuesday, May 12, 2009, at 4:30 PM EST, after the markets close. During the call, M. Denis Connaghan, etrials' president and chief executive officer, and Joseph (Jay) Trepanier III, chief financial officer, will discuss the Company's quarterly performance and financial results.
To participate in the live earnings call by telephone, please dial 800-480-2207, or, for international callers, please dial 706-643-7866 and reference ID number 97058686. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's Web site at www.etrials.com. Please go to the Web site 15 minutes prior to the scheduled start to register, and install any necessary audio software. A Web cast audio replay and a telephone audio replay will also be available for two weeks following the call by dialing 800-642-1687 from the US or 706-645-9291 for international callers, and entering conference ID number 97058686 when prompted.
This news release contains "forward-looking statements," including statements which are related to future, not past, events. Forward-looking statements usually describe expected future business and financial outlook or performance, and often contain words such as “will,” “believes,” “intends,” “anticipates,” “expects,” "plans," "seeks," “see” and similar expressions. Forward-looking statements, by their nature, address matters that are, to varying degrees, uncertain and subject to various known and unknown risks. Such forward-looking statements include Merge’s and etrials’ decision to enter into an agreement for Merge to acquire etrials, the ability of the parties to complete the transaction contemplated by the merger agreement, including the parties’ ability to satisfy the conditions set forth in the merger agreement, and the possibility of any termination of the merger agreement. For Merge, particular uncertainties and risks that could cause actual results to differ materially from post-merger forward-looking statements include: the consummation and the successful integration of etrials into Merge; market acceptance and performance of its products and services; the impact of competitive products and pricing; possible delays in the implementation of its managed services offering; the risks and effects of its recent changes in its executive and Board leadership; the risks and effects of its recent securities issues, including the issuance of certain senior secured notes; the past restatement of its financial statements and other actions that may be taken or required as a result of such restatement; its ability to generate sufficient cash from operations to meet future operating, financing and capital requirements, including repayment obligations with respect to its outstanding indebtedness; risks associated with its prior delays in filings with the SEC or its ability to continue to meet the listing requirements of The NASDAQ Stock Market; the costs, risks and effects of various pending legal proceedings and investigations, including the formal investigation being conducted by the Securities and Exchange Commission; and other risk factors detailed in its filings with the Securities and Exchange Commission. More information about potential factors which could cause etrials’ actual results to differ from the forward-looking statements included in this announcement is included in its filings with the Securities and Exchange Commission, including the “Risk Factors” Section of its Form 10-K filed on March 10, 2009. These uncertainties and risks may cause its actual future results to be materially different than those expressed in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Neither Merge nor etrials undertakes any obligation to update such forward-looking statements or any of such risks, uncertainties and other factors.